Transcription of [Product Monograph Template - Standard]
{{id}} {{{paragraph}}}
NATESTO product Monograph product Monograph INCLUDING PATIENT MEDICATION INFORMATION NATESTO Testosterone nasal gel w/w Androgens Acerus Pharmaceuticals SRL Durants, Business Centre, Suite B Durants, Christ Church Barbados, BB17097 Imported by: Acerus Pharmaceuticals Corporation 2486 Dunwin Drive, Mississauga, Ontario L5L 1J9 Date of Revision: October 25, 2016 Submission Control No: 195395 NATESTO product Monograph Page 2 of 39 Table of Contents PART I: HEALTH PROFESSIONAL INFORMATION ..3 SUMMARY product INFORMATION ..3 INDICATIONS AND CLINICAL USE ..3 CONTRAINDICATIONS ..3 WARNINGS AND PRECAUTIONS ..4 ADVERSE REACTIONS ..9 drug INTERACTIONS ..13 DOSAGE AND ADMINISTRATION ..14 OVERDOSAGE ..17 ACTION AND CLINICAL PHARMACOLOGY ..17 STORAGE AND STABILITY ..21 SPECIAL HANDLING INSTRUCTIONS ..21 DOSAGE FORMS, COMPOSITION AND PACKAGING ..21 PART II: SCIENTIFIC INFORMATION.
NATESTO™ Product Monograph Page 6 of 39 Endocrine and Metabolism Androgens have been shown to alter glucose tolerance tests. Diabetics should be followed carefully and the insulin or oral hypoglycemic dosage adjusted accordingly (see Drug-Drug
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document:
{{id}} {{{paragraph}}}
Oral Cancer Drug Therapy Safe Use and Safe, Oral cancer drug, British Columbia Cancer Agency POLICY, Hazardous Drug Safe Handling Standards, Cancer, Therapy, Safe, Safe Prescribing, Handling and Administration of, Against Cancer, Oral, Drug Management and Prior Authorization, DRUG, Supporting Continuity of Care for Cancer, Thiotepa, Thiotepa DRUG